Skip to main content
OpenTrials

Clinical trial condition

Hyperpituitarism

Explore clinical trials studying Hyperpituitarism. Study availability and eligibility vary by location and protocol.

211 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Hyperpituitarism trial results

Completed

Non Interventional Post Marketing Programme in Acromegaly

NCT00747500

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Aberdeen Royal Infirmary Aberdeen, United Kingdom
  • Barnsley General Hospital Barnsley, United Kingdom
  • University Hospital Coventry & Warwickshire Coventry, United Kingdom
  • Leeds General Infirmary Leeds, United Kingdom
View Trial Details
Completed

Validation Study of the SAGIT® Instrument in Acromegaly

NCT02539927

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +8 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • The Emory Pituitary Center Atlanta, Georgia, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • Endocrinology and Metabolism Pittsburgh, Pennsylvania, United States
View all 33 locations
View Trial Details
Completed

Rhinological Outcomes in Endonasal Pituitary Surgery

NCT01504399

Conditions
Acromegaly, Adenoma, Adrenal Gland Diseases, +26 more
Locations
  • Barrow Neurological Institute/St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • John Wayne Cancer Institute at St. John's Health Center Santa Monica, California, United States
  • Northshore University Health System Chicago, Illinois, United States
  • Ohio State University Medical Center Columbus, Ohio, United States
View Trial Details
Completed

An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.

NCT01582061

Conditions
Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +15 more
Locations
  • Advanced Research, LLC Peoria, Arizona, United States
  • St Josephs Hospital & Medical Center St Joes Phoenix, Arizona, United States
  • University of California at Los Angeles UCLA Tiverton Los Angeles, California, United States
  • LA Biomedical Research at Harbor UCLA Medical Center Torrance, California, United States
View all 65 locations
View Trial Details
Completed

Efficacy and Safety of Pasireotide Long Acting Release (LAR) Versus Octreotide LAR or Lanreotide Autogel (ATG) in Patients With Inadequately Controlled Acromegaly

NCT01137682

Conditions
Acromegaly, Bone Diseases, Bone Diseases, Endocrine, +17 more
Locations
  • University of Michigan Ann Arbor, Michigan, United States
  • Oregon Health & Science University Portland, Oregon, United States
  • University of Texas Southwestern Medical Center Division of Hematology/Oncolog Dallas, Texas, United States
  • Swedish Neuroscience Institute 550 17th Avenue, Suite 500 Seattle, Washington, United States
View all 60 locations
View Trial Details

Related conditions